Who owns Travere Therapeutics, Inc. (RTRX)? Elite investor 13F holders
4 tracked elite investors reported holding Travere Therapeutics, Inc as of 2026-09-30, including Renaissance Technologies LLC, D.E. Shaw, Polen Capital Management, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | TRAVERE THERAPEUTICS INC | SHARE | 2026-09-30 | 2026-11-12 00:00:00 | 63477292.00 USD | 1078079.000000 | Shares | reduce | Original filing |
| D.E. Shaw | TRAVERE THERAPEUTICS INC | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 40818972.00 USD | 693257.000000 | Shares | reduce | Original filing |
| D.E. Shaw | TRAVERE THERAPEUTICS INC | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 0.00 USD | 0.000000 | Principal | exited | Original filing |
| Polen Capital Management | TRAVERE THERAPEUTICS INC | SHARE | 2026-09-30 | 2026-11-13 00:00:00 | 3119933.00 USD | 52988.000000 | Shares | add | Original filing |
| Gotham Asset Management | TRAVERE THERAPEUTICS INC | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 2082821.00 USD | 35374.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.